Ads
related to: Psoriasis Treatment and Psoriatic Arthritis
Search results
What Is Psoriatic Arthritis? 3 MDs Weigh In
PopSugar· 2 weeks agoPsoriasis affects about three percent of American adults, but the disorder can raise the risk of having more than skin scales and plaques. About 30 percent of people with ...
Psoriasis pain: Prevalence and how to manage it
Medical News Today· 2 weeks agoPeople may describe psoriasis pain as itchy, achy, or stinging, with the feeling varying from person to person. Strategies such as using distraction,...
Amjevita and dosage: Strengths, forms, how to inject, and more
Medical News Today· 1 week agoAmjevita comes as a solution subcutaneous injection. Your doctor will determine the best dosage to...
Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...
Rome Sentinel· 4 days agoAdalimumab-aaty is also available from Celltrion USA under the brand name YUFLYMA®, which launched in July 2023 and is available at a 5% discount to the current WAC list price of HUMIRA. Adalimumab-aaty ...
Janssen-Cilag seeks expanded EMA approval for TREMFYA
Pharmaceutical Technology via Yahoo Finance· 2 weeks agoTreatment with guselkumab also offered statistically significant and clinically meaningful...
Amgen (AMGN) Scheduled to Post Earnings on Thursday
ETF DAILY NEWS· 2 weeks agoAmgen (NASDAQ:AMGN – Get Free Report) is set to announce its earnings results after the market closes on Thursday, May 2nd. Analysts expect the company to announce earnings of $3.82 per share ...
Stelara interactions: Other medications, alcohol, and more
Medical News Today· 3 days agoStelara (ustekinumab) is a brand-name injectable drug prescribed for certain autoimmune conditions....
Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
Zacks via Yahoo Finance· 1 week agoTremfya is presently approved to treat certain patients with plaque psoriasis and active psoriatic ...
3 Tried and True Dividend Stocks to Buy for Your Portfolio
InvestorPlace· 6 days agoPicking income stocks can be challenging. It varies year to year, but holding solid income stocks...
Amgen (NASDAQ:AMGN) Shares Down 2.7% on Insider Selling
ETF DAILY NEWS· 7 days agoAmgen Inc. (NASDAQ:AMGN – Get Free Report) shares were down 2.7% on Monday after an insider sold shares in the company. The company traded as low as $301.09 and last traded at $302.91. Specifically ...